Understand how current basic cell research will translate into patient care of the future. Understand the regulatory requirements of cell based research/therapy Understand how experience from more mature cellular research areas such hematopoietic stem cell transplantation can apply to emerging areas of research in non-hematopoietic areas such as mesenchymal stem cell and islet cell transplantation Plenary Sessions: Mesenchymal Stem Cells Antigen-Specific and Engineered T Cells Tissue Engineering and Regenerative Medicine Cardiovascular Cell Therapy Umbilical Cord Blood Stem Cell Translational Science Technical Applications Track
EDUCATIONAL PROGRAM CLICK HERE
CORPORATE PROGRAM CLICK HERE
Who should attend:
This activity is designed for MD and PhD clinicians, scientists, researchers, technologists, regulatory professionals and industry experts.
Meeting Learning Objectives:
Each of the six didactic Plenary Sessions are CME accredited for a total of 9 hours of credit.
Immune Regulatory Cells
Chair: Robert Negrin, MD, PhD
Speakers: Mattias Edinger, MD, PhD and Massimo Martelli, MD
Chair: Edwin Horwitz, MD, PhD
Speakers: Reza Abdi, MD and Khalid Shah, PhD
Chair: Carl June, MD
Speakers: Dorothee von Laer, MD and Michel Sadelain, MD, PhD
Chair: Chris Mason, MBBS, PhD, FRCS
Speakers: Robert Nerem, PhD and Paolo Macchiarini, MD, PhD
Chair: Warren Sherman, MD, F.A.C.C., F.S.C.A.I.
Speakers: Amit N. Patel, MD, MS and Marc S. Penn, MD, PhD
Chair: Mary Laughlin, MD
Speakers: Juliet Barker, MBBS, Mariusz Ratajczak, MD, PhD, d.hc and Vanderson Rocha, MD
Strategies for Commercialization Track